Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Giesemann

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|September 29, 2007
Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate bindingThomas Jank, Torsten Giesemann, Klaus Aktories
Glycobiology|January 24, 2007
Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and functionThomas Jank, Torsten Giesemann, Klaus Aktories
Gastroenterology|April 26, 2008
Human alpha-defensins inhibit Clostridium difficile toxin BTorsten Giesemann, Gregor Guttenberg, Klaus Aktories
The Journal of Biological Chemistry|December 3, 2008
Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphateMartina Egerer, Torsten Giesemann, Christian Herrmann, et al.
Journal of Medical Microbiology|May 16, 2008
Processing of Clostridium difficile toxinsTorsten Giesemann, Martina Egerer, Thomas Jank, et al.
The Journal of Biological Chemistry|May 17, 2006
Exchange of a single amino acid switches the substrate properties of RhoA and RhoD toward glucosylating and transglutaminating toxinsThomas Jank, Ulrike Pack, Torsten Giesemann, et al.
Planta Medica|May 11, 2012
In vitro cytotoxicity of cyclodextrin-bonded birch bark extractAnke Hertrampf, Carsten Gründemann, Sebastian Jäger, et al.
The Journal of Biological Chemistry|September 15, 2005
Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesisThomas Jank, Dirk J Reinert, Torsten Giesemann, et al.
The Journal of Biological Chemistry|June 27, 2007
Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activityMartina Egerer, Torsten Giesemann, Thomas Jank, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2011
Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistanceRebekka Krumbach, Julia Schüler, Michael Hofmann, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|September 29, 2007
Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate bindingThomas Jank, Torsten Giesemann, Klaus Aktories
Glycobiology|January 24, 2007
Rho-glucosylating Clostridium difficile toxins A and B: new insights into structure and functionThomas Jank, Torsten Giesemann, Klaus Aktories
Gastroenterology|April 26, 2008
Human alpha-defensins inhibit Clostridium difficile toxin BTorsten Giesemann, Gregor Guttenberg, Klaus Aktories
The Journal of Biological Chemistry|December 3, 2008
Autocatalytic processing of Clostridium difficile toxin B. Binding of inositol hexakisphosphateMartina Egerer, Torsten Giesemann, Christian Herrmann, et al.
Journal of Medical Microbiology|May 16, 2008
Processing of Clostridium difficile toxinsTorsten Giesemann, Martina Egerer, Thomas Jank, et al.
The Journal of Biological Chemistry|May 17, 2006
Exchange of a single amino acid switches the substrate properties of RhoA and RhoD toward glucosylating and transglutaminating toxinsThomas Jank, Ulrike Pack, Torsten Giesemann, et al.
Planta Medica|May 11, 2012
In vitro cytotoxicity of cyclodextrin-bonded birch bark extractAnke Hertrampf, Carsten Gründemann, Sebastian Jäger, et al.
The Journal of Biological Chemistry|September 15, 2005
Change of the donor substrate specificity of Clostridium difficile toxin B by site-directed mutagenesisThomas Jank, Dirk J Reinert, Torsten Giesemann, et al.
The Journal of Biological Chemistry|June 27, 2007
Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activityMartina Egerer, Torsten Giesemann, Thomas Jank, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2011
Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: activation of MET as one mechanism for drug resistanceRebekka Krumbach, Julia Schüler, Michael Hofmann, et al.
Pageof 2